BioMarin Pharmaceutical Inc. buy Bank of America Co.
Start price
11.03.26
/
50%
€52.12
Target price
11.03.27
€73.15
Performance (%)
-10.78%
Price
10.04.26
€46.50
Summary
This prediction is currently active. The prediction for BioMarin Pharmaceutical Inc. disappoints with a performance of -10.78%. This prediction currently runs until 11.03.27. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| BioMarin Pharmaceutical Inc. | -3.367% | -3.367% |
| iShares Core DAX® | 2.554% | -0.112% |
| iShares Nasdaq 100 | 2.742% | -0.470% |
| iShares Nikkei 225® | 6.584% | 3.221% |
| iShares S&P 500 | 1.930% | -0.519% |
Comments by Bank_of_America_Co_ for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical (BMRN) had its price target lowered by Bank of America Corporation from $97.00 to $85.00. They now have a "buy" rating on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€68.34
20.02.25
20.02.25
€98.56
20.02.26
20.02.26
-21.69%
21.02.26
21.02.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€62.80
17.09.24
17.09.24
€103.34
17.09.25
17.09.25
-26.54%
18.09.25
18.09.25